BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 536202)

  • 1. Autopsy experience with a radioactive cadaver.
    Johnston AS; Minarcik J; Rossi R; Pinsky S
    Health Phys; 1979 Aug; 37(2):231-6. PubMed ID: 536202
    [No Abstract]   [Full Text] [Related]  

  • 2. Management and autopsy of a radioactive cadaver.
    Wallace AB; Bush V
    Australas Phys Eng Sci Med; 1991 Jun; 14(2):119-24. PubMed ID: 1747080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of ¹³¹I in households of thyroid cancer patients.
    North DL
    Health Phys; 2013 Apr; 104(4):434-6. PubMed ID: 23439148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of the radioactive body burden in patients receiving iodine-131 treatment for carcinoma of the thyroid.
    Ravichandran R; Supe SS; Jayasree U; Devaru S
    Eur J Nucl Med; 1997 Apr; 24(4):464. PubMed ID: 9198581
    [No Abstract]   [Full Text] [Related]  

  • 5. Restrictions following iodine-131 treatment--a time for change or more data required?
    Mountford PJ; O'Doherty MJ
    Eur J Nucl Med; 1994 Sep; 21(9):903-5. PubMed ID: 7995282
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation exposure to the family of radioactive patients.
    Harbert JC; Wells N
    J Nucl Med; 1974 Oct; 15(10):887-8. PubMed ID: 4418007
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation safety in the management of patients undergoing radioactive iodine ablation therapy.
    Beck M
    Clin J Oncol Nurs; 2015 Feb; 19(1):44-6. PubMed ID: 25689648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
    Marcus CS; Siegel JA
    J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of radioactive iodine in the treatment of differentiated thyroid cancer: physiopathological basis, results, considerations from the viewpoint of radioprotection].
    Frühling J
    Bull Mem Acad R Med Belg; 1994; 149(3-4):195-206; discussion 206-8. PubMed ID: 7841930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposures from environmental radioactivity: international safety standards.
    Balonov M;
    Appl Radiat Isot; 2008 Nov; 66(11):1546-9. PubMed ID: 18508274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
    Siekierzyński M
    Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care of a helpless patient and handling of the radioactive corpse.
    Osborn S
    J Radiol Prot; 2002 Jun; 22(2):185; author reply 186-7. PubMed ID: 12148793
    [No Abstract]   [Full Text] [Related]  

  • 13. Exposure of embalmers and physicians by radioactive cadavers.
    Laughlin JS; Vacirca SJ; Duplissey JF
    Health Phys; 1968 Nov; 15(5):451-5. PubMed ID: 5722813
    [No Abstract]   [Full Text] [Related]  

  • 14. Necropsy of a cadaver containing 50 mCi of sodium131 iodide.
    Parthasarathy KL; Komerek M; Quain B; Bakshi SP; Qureshi F; Shimaoka K; Rao U; Adamski JS; Bender MA
    J Nucl Med; 1982 Sep; 23(9):777-80. PubMed ID: 7108623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on 'Radioiodine therapy: care of the helpless patient and handling of the radioactive corpse'.
    Dalgleish JR
    J Radiol Prot; 2002 Sep; 22(3):313-4; author reply 314-5. PubMed ID: 12375793
    [No Abstract]   [Full Text] [Related]  

  • 16. [Shielding effect of distance in (131)I-131 therapy for differentiated thyroid cancer].
    Chi X; Liu F; Li G; Wang Q; Deng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):286-8. PubMed ID: 24589615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Care of a terminally ill patient following a thyroid ablation dose of (131)I-sodium iodide.
    Denman AR; Martin S
    Br J Radiol; 2001 Nov; 74(887):1077-8. PubMed ID: 11709478
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.
    Sgouros G
    J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.
    Al-Haj AN; Lagarde CS; Lobriguito AM
    Health Phys; 2007 Dec; 93(6):656-66. PubMed ID: 17993846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models.
    Willegaignon J; Guimarães MI; Stabin MG; Sapienza MT; Malvestiti LF; Marone MM; Sordi GM
    Health Phys; 2007 Dec; 93(6):678-88. PubMed ID: 17993848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.